These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26365023)
1. Safety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial. Hassanein SM; Deifalla SM; El-Houssinie M; Mokbel SA J Clin Neurol; 2016 Jan; 12(1):79-84. PubMed ID: 26365023 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease. Bae CY; Cho CY; Cho K; Hoon Oh B; Choi KG; Lee HS; Jung SP; Kim DH; Lee S; Choi GD; Cho H; Lee H J Am Geriatr Soc; 2000 Dec; 48(12):1566-71. PubMed ID: 11129744 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. Alvarez XA; Cacabelos R; Sampedro C; Aleixandre M; Linares C; Granizo E; Doppler E; Moessler H Eur J Neurol; 2011 Jan; 18(1):59-68. PubMed ID: 20500802 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms. Xiao S; Xue H; Li G; Yuan C; Li X; Chen C; Wu HZ; Mitchell P; Zhang M Aust N Z J Psychiatry; 2012 Feb; 46(2):153-60. PubMed ID: 22311531 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease. Wei ZH; He QB; Wang H; Su BH; Chen HZ J Neural Transm (Vienna); 2007; 114(5):629-34. PubMed ID: 17318304 [TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke. Lang W; Stadler CH; Poljakovic Z; Fleet D; Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193 [TBL] [Abstract][Full Text] [Related]
14. Effects of Cerebrolysin® in Patients With Minimally Conscious State After Stroke: An Observational Retrospective Clinical Study. Kim JY; Kim HJ; Choi HS; Park SY; Kim DY Front Neurol; 2019; 10():803. PubMed ID: 31428035 [No Abstract] [Full Text] [Related]
15. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke]. Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. Ladurner G; Kalvach P; Moessler H; J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955 [TBL] [Abstract][Full Text] [Related]
18. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study. Stan A; Birle C; Blesneag A; Iancu M J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596 [No Abstract] [Full Text] [Related]
19. Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke. Amiri-Nikpour MR; Nazarbaghi S; Ahmadi-Salmasi B; Mokari T; Tahamtan U; Rezaei Y Neuropsychiatr Dis Treat; 2014; 10():2299-306. PubMed ID: 25516711 [TBL] [Abstract][Full Text] [Related]
20. Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke. Chang WH; Park CH; Kim DY; Shin YI; Ko MH; Lee A; Jang SY; Kim YH BMC Neurol; 2016 Mar; 16():31. PubMed ID: 26934986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]